had you been vaxxed, chances are you wouldn't have gotten it in the first place, or at least had minimal symptoms.
think about it - had you not had any symptoms & been a carrier, someone you infected could very well have died.
Instead he’s just going to recover from Fauxi Flu then will have a stronger immunity than the test subjects of Big Pharma.
The vaccine also protects against variants, which this guy won't have.
Bullshit. Studies have shown natural immunity provides better protection against the variants than mRNA experimental “vaccine” does. The so-called vaccine doesn’t even give a 99% immunity rate for normal WuFlu.
June 8, 2021
How COVID-19 variants evade immune response
At a Glance
- Research revealed how certain mutations in circulating SARS-CoV-2 variants allow the virus to avoid neutralization by many antibodies.
-
- The results suggest how to develop more broadly effective therapies and vaccines.
Scientists gained insights into how SARS-CoV-2 variants (blue) may escape neutralization from antibodies (yellow). koto_feja / iStock / Getty Images Plus
SARS-CoV-2, the virus that causes COVID-19, uses a protein called the spike protein to recognize and enter host cells. Recent SARS-CoV-2 variants contain changes, or mutations, at a key site on the spike protein called the receptor-binding site (RBS).
Some of these mutations render antibodies elicited against earlier virus strains less effective. This allows the variants to partially escape the immune response produced after vaccination or prior infection. It raises concerns that new variants could make existing vaccines less effective and draw out the pandemic.
Researchers led by Dr. Ian Wilson at the Scripps Research Institute examined how and why certain mutations protect the virus. NIH’s National Institute of Allergy and Infectious Diseases (NIAID) supported the research, which appeared in
Science on May 20, 2021.
How COVID-19 variants evade immune response
COVID-19
SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies
In contrast to the rapid evolution of other RNA viruses, SARS-CoV-2 has low genomic variability because of its proofreading function. Therefore, to try to control the pandemic, researchers rushed to make vaccines and monoclonal antibodies (mAbs) tailored to the viral sequence initially identified in Wuhan, China. Thanks to incredible technological progress, huge public-sector investments and global scientific collaboration, vaccines with efficacy of up to 95% and lifesaving mAbs were developed and approved for emergency use, at a speed never achieved before.
Many of these mutations identified in infected people are also found as escape mutations during in vitro experiments in which the virus or a pseudovirus is incubated with neutralizing mAbs or convalescent serum from people who have recovered from COVID-19; this suggests that these variants are observed because they keep spreading even in populations that have already acquired some immunity after natural infection
8. The convergence toward similar mutations is probably explained by the need to escape the predominant neutralizing antibody response, which derives mostly from antibodies encoded by the immunoglobulin G heavy-chain variable germline regions
IGHV3-53 and
IGHV3-669. Indeed, convalescent serum has limitations in its ability to tackle the B.1.351 and B.1.1.248 variants. Such serum samples can show a four- to ninefold lower neutralization ability when faced with variants than their efficacy against the original SARS-CoV-2 virus identified in Wuhan; moreover, 40–48% of such serum samples completely lack neutralization ability
1,
2,
4,
10. By contrast, the B.1.1.7 variant only moderately affects the neutralization ability of convalescent serum
2,
10.
These variants are having a striking societal effect. A key example is the situation in Manaus, Brazil, where variants have re-infected people and have spread in a population in which over 76% of people were already SARS-CoV-2 seropositive
11
SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies